iguratimod has been researched along with Adverse Effects, Long Term in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, Y; Kobayashi, M; Ohsone, Y; Okano, Y; Taguchi, H; Tono, T | 1 |
1 other study(ies) available for iguratimod and Adverse Effects, Long Term
| Article | Year |
|---|---|
Pneumocystis jirovecii pneumonia developed in a patient with rheumatoid arthritis after 14 weeks of iguratimod add-on to treatment with methotrexate and etanercept.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Drug Therapy, Combination; Etanercept; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Long Term Adverse Effects; Methotrexate; Pneumocystis carinii; Pneumonia, Pneumocystis; Sulfonamides | 2018 |